Cargando…

GeneXpert—A Game-Changer for Tuberculosis Control?

Carlton Evans considers whether the new tuberculosis diagnostic test, GeneXpert, is the solution for TB control that it's said to be.

Detalles Bibliográficos
Autor principal:	Evans, Carlton A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144196/ https://www.ncbi.nlm.nih.gov/pubmed/21814497 http://dx.doi.org/10.1371/journal.pmed.1001064

Ejemplares similares

Equivalence of the GeneXpert System and GeneXpert Omni System for tuberculosis and rifampicin resistance detection
por: Georghiou, Sophia B., et al.
Publicado: (2021)

GeneXpert in stool: Diagnostic yield in Intestinal Tuberculosis
por: Talib, Abu, et al.
Publicado: (2019)

Leveraging polymerase chain reaction technique (GeneXpert) to upscaling testing capacity for SARS-CoV-2 (COVID-19) in Nigeria: a game changer
por: Oladimeji, Olanrewaju, et al.
Publicado: (2020)

Transoral Thyroidectomy: Is It a Real Game Changer?
por: Tae, Kyung
Publicado: (2020)

Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis
por: Metcalf, Tatiana, et al.
Publicado: (2018)

Could Digital Therapeutics be a Game Changer in Psychiatry?
por: Cho, Chul-Hyun, et al.
Publicado: (2019)

Diagnostic Accuracy of Sputum Microscopy in Comparison With GeneXpert in Pulmonary Tuberculosis
por: Umair, Masab, et al.
Publicado: (2020)

Effectiveness of GeneXpert(®) in the diagnosis of tuberculosis in people living with HIV/AIDS
por: de Faria, Mariana Gaspar Botelho Funari, et al.
Publicado: (2021)

Evaluation of the GeneXpert for Human Monkeypox Diagnosis
por: Li, Daniel, et al.
Publicado: (2017)

GeneXpert for the diagnosis of COVID-19 in LMICs
por: Rakotosamimanana, Niaina, et al.
Publicado: (2020)

Contributions of GeneXpert(®) to TB diagnosis in Myanmar
por: Burger, Z., et al.
Publicado: (2022)

Role of GeneXpert MTB/Rif Assay in Diagnosing Tuberculosis in Pregnancy and Puerperium
por: Habib, Zaiyad G., et al.
Publicado: (2015)

Evaluation of GeneXpert MTB/RIF assay for direct diagnosis of pulmonary tuberculosis
por: Moussa, Husseiny Sh., et al.
Publicado: (2016)

Evaluation of GeneXpert MTB/RIF system performances in the diagnosis of extrapulmonary tuberculosis
por: Mechal, Youness, et al.
Publicado: (2019)

GeneXpert on patients with human immunodeficiency virus and smear-negative pulmonary tuberculosis
por: Cuong, Nguyen Kim, et al.
Publicado: (2021)

GeneXpert Technology for the diagnosis of HIV-associated tuberculosis: Is scale-up worth it?
por: Saeed, Muhammad, et al.
Publicado: (2020)

Diagnosing an atypical case of tuberculosis presenting as dacryocystitis: Sac biopsy and GeneXpert
por: Lokdarshi, Gautam, et al.
Publicado: (2022)

Missed opportunities for integrated testing of HIV and tuberculosis on the GeneXpert platform in Lesotho
por: Gwaza, Gamuchirai P., et al.
Publicado: (2023)

Venetoclax: a real game changer in treatment of chronic lymphocytic leukemia
por: Molica, Stefano
Publicado: (2020)

GeneXpert for TB diagnosis: planned and purposeful implementation
por: Piatek, Amy S, et al.
Publicado: (2013)

Evaluation of GeneXpert MTB/RIF for detecting Mycobacterium tuberculosis in a hospital in China
por: Tang, Tingyu, et al.
Publicado: (2017)

Genotypic, Phenotypic and Clinical Validation of GeneXpert in Extra-Pulmonary and Pulmonary Tuberculosis in India
por: Singh, Urvashi B., et al.
Publicado: (2016)

GeneXpert MTB/RIF assay in the diagnosis of urinary tuberculosis from urine specimens
por: Pang, Yu, et al.
Publicado: (2017)

GeneXpert(®) MTB/RIF assay with transbronchial lung cryobiopsy for Mycobacterium tuberculosis diagnosis
por: Sánchez-Cabral, Olivia, et al.
Publicado: (2020)

Limited role of GeneXpert in peritoneal fluid in the diagnosis of genital tuberculosis in infertile women
por: Agrawal, Smriti, et al.
Publicado: (2021)

Covid-19 – A Game Changer for Medical Education? Reflections from England
por: Vaux, Emma, et al.
Publicado: (2021)

WHO laboratory validation of Xpert(®) CT/NG and Xpert(®) TV on the GeneXpert system verifies high performances
por: Jacobsson, Susanne, et al.
Publicado: (2018)

Cost-effectiveness of GeneXpert and LED-FM for diagnosis of pulmonary tuberculosis: A systematic review
por: Sagili, Karuna D., et al.
Publicado: (2018)

Evaluation of the use of GeneXpert MTB/RIF in a zone with high burden of tuberculosis in Thailand
por: Pongpeeradech, Nathakorn, et al.
Publicado: (2022)

The Value of GeneXpert MTB/RIF for Detection in Tuberculosis: A Bibliometrics-Based Analysis and Review
por: Li, Zhiyi
Publicado: (2022)

The Role of GeneXpert(®) for Tuberculosis Diagnostics in Brazil: An Examination from a Historical and Epidemiological Perspective
por: Iúdice, Tirça Naiara da Silva, et al.
Publicado: (2023)

Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis
por: Nhu, Nguyen Thi Quynh, et al.
Publicado: (2014)

Public investments in the development of GeneXpert molecular diagnostic technology
por: Gotham, Dzintars, et al.
Publicado: (2021)

Use of GeneXpert Remnants for Drug Resistance Profiling and Molecular Epidemiology of Tuberculosis in Libreville, Gabon
por: Alame-Emane, Amel Kévin, et al.
Publicado: (2017)

Feasibility and Sensitivity of Saliva GeneXpert MTB/RIF Ultra for Tuberculosis Diagnosis in Adults in Uganda
por: Byanyima, Patrick, et al.
Publicado: (2022)

Game Changers
Publicado: (2014)

Game Changers
Publicado: (2014)

Game Changers
Publicado: (2015)

Game Changers
Publicado: (2015)

Game changers
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ldinmaba5qb4kge57oovka3m0h